Catalytic Mechanism of SARS-CoV-2 3-Chymotrypsin-Like Protease as Determined by Steady-State and Pre-Steady-State Kinetics
Open Access
- 27 November 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 14 (24) , 18292-18309
Abstract
The 3-chymotrypsin-like protease (3CL-PR; also known as Main protease) of SARS-CoV-2 is a cysteine protease that is the target of the COVID-19 drug, Paxlovid. Here, we report for 3CL-PR, the pH-rate profiles of a substrate, an inhibitor, affinity agents, and solvent kinetic isotope effects (sKIEs) obtained under both steady-state and pre-steady-state conditions. "Bell-shaped" plots of log(k cat/K a) vs pH for the substrate (Abz)SAVLQ*SGFRK(Dnp)-NH2 and pK i vs pH for a peptide aldehyde inhibitor demonstrated that essential acidic and basic groups of pK 2 = 8.2 ± 0.4 and pK 1 = 6.2 ± 0.3, respectively, are required for catalysis, and the pH-dependence of inactivation of 3CL-PR by iodoacetamide and diethylpyrocarbonate identified enzymatic groups of pK 2 = 7.8 ± 0.1 and pK 1 = 6.05 ± 0.07, which must be unprotonated for maximal inactivation. These data are most consistent with the presence of a neutral catalytic dyad (Cys-SH-His) in the 3CL-PR free enzyme, with respective pK values for the cysteine and histidine groups of pK 2 = 8.0 and pK 1 = 6.5. The steady-state sKIEs were D2O(k cat/K a) = 0.56 ± 0.05 and D2O k cat = 1.0 ± 0.1, and sKIEs indicated that the Cys-S--HisH+ tautomer was enriched in D2O. Presteady-state kinetic analysis of (Abz)SAVLQ*SGFRK(Dnp)-NH2 exhibited transient lags preceding steady-state rates, which were considerably faster in D2O than in H2O. The transient rates encompass steps that include substrate binding and acylation, and are faster in D2O wherein the more active Cys-S--HisH+ tautomer predominates. A full catalytic mechanism for 3CL-PR is proposed.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R21AI166624)
- Texas A&M AgriLife Research
This publication has 52 references indexed in Scilit:
- The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizationsMedicinal Chemistry Research, 2022
- Evaluation of Enzyme Inhibitors in Drug Discovery2013
- Increased Protein Structural Resolution from Diethylpyrocarbonate-based Covalent Labeling and Mass Spectrometric DetectionJournal of the American Society for Mass Spectrometry, 2012
- Challenging a paradigm: Theoretical calculations of the protonation state of the Cys25‐His159 catalytic diad in free papainProteins: Structure, Function, and Bioinformatics, 2009
- The Behavior and Significance of Slow‐Binding Enzyme Inhibitors1988
- Kinetic studies of the reactions catalyzed by glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides: pH variation of kinetic parametersArchives of Biochemistry and Biophysics, 1984
- Is the thiolate—imidazolium ion pair the catalytically important form of papain?FEBS Letters, 1980
- Solvent isotope effects on tautomerization equilibria of papain and model thiolaminesFEBS Letters, 1980
- Determining the Chemical Mechanisms of Enzyme‐Catalyzed Reactions by Kinetic Studies1977
- Mercaptide—imidazolium ion‐pair: The reactive nucleophile in papain catalysisFEBS Letters, 1974